- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x PA1- GCS- KDO- GMH- GMH- KDO: L-glycero-alpha-D-manno-heptopyranose-(1-3)-L-glycero-alpha-D-manno-heptopyranose-(1-5)-[3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid-(2-4)]3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid-(2-6)-2-amino-2-deoxy-beta-D-glucopyranose-(1-6)-2-amino-2-deoxy-alpha-D-glucopyranose
- 4 x FTT: 3-HYDROXY-TETRADECANOIC ACID(Non-covalent)(Non-functional Binders)
FTT.2: 10 residues within 4Å:- Chain A: Y.265, Q.279, F.336, F.361, R.363
- Ligands: PA1-GCS-KDO-GMH-GMH-KDO.1, FTT.3, FTT.4, DAO.5, DPO.29
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.336, A:F.361
- Hydrogen bonds: A:R.363
FTT.3: 6 residues within 4Å:- Ligands: PA1-GCS-KDO-GMH-GMH-KDO.1, FTT.2, FTT.4, DAO.5, LDA.27, LDA.28
No protein-ligand interaction detected (PLIP)FTT.4: 10 residues within 4Å:- Chain A: F.283, Q.334, R.363
- Ligands: PA1-GCS-KDO-GMH-GMH-KDO.1, PA1-GCS-KDO-GMH-GMH-KDO.1, FTT.2, FTT.3, DAO.5, FTT.6, LDA.27
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.283, A:F.283
- Hydrogen bonds: A:R.363, A:R.363
FTT.6: 8 residues within 4Å:- Chain A: F.212, F.283, E.285
- Ligands: PA1-GCS-KDO-GMH-GMH-KDO.1, FTT.4, MYR.7, LDA.27, PO4.30
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.212, A:F.283, A:F.283
- 1 x DAO: LAURIC ACID(Non-covalent)
- 1 x MYR: MYRISTIC ACID(Non-covalent)
- 20 x LDA: LAURYL DIMETHYLAMINE-N-OXIDE(Non-covalent)(Non-functional Binders)
LDA.8: 11 residues within 4Å:- Chain A: V.145, F.147, T.157, G.158, F.159, L.178, Y.194, A.195, F.216, Q.217, N.218
Ligand excluded by PLIPLDA.9: 5 residues within 4Å:- Chain A: V.359, T.424, V.426, W.447, D.449
Ligand excluded by PLIPLDA.10: 6 residues within 4Å:- Chain A: V.426, V.428, Y.445, W.447, K.466
- Ligands: LDA.21
Ligand excluded by PLIPLDA.11: 6 residues within 4Å:- Chain A: V.428, L.441, G.442, G.443, F.468, W.470
Ligand excluded by PLIPLDA.12: 6 residues within 4Å:- Chain A: F.486, Y.513, V.515, N.534, T.536
- Ligands: LDA.25
Ligand excluded by PLIPLDA.13: 6 residues within 4Å:- Chain A: N.480, V.482, V.517, Y.519, R.524, V.528
Ligand excluded by PLIPLDA.14: 7 residues within 4Å:- Chain A: P.204, D.205, T.208, F.210, Y.265, F.267
- Ligands: 3PH.26
Ligand excluded by PLIPLDA.15: 2 residues within 4Å:- Chain A: Y.171, W.202
Ligand excluded by PLIPLDA.16: 4 residues within 4Å:- Chain A: F.346, A.347, L.355
- Ligands: LDA.17
Ligand excluded by PLIPLDA.17: 6 residues within 4Å:- Chain A: T.274, S.344, F.346, T.357
- Ligands: LDA.16, LDA.18
Ligand excluded by PLIPLDA.18: 3 residues within 4Å:- Chain A: N.272, F.275
- Ligands: LDA.17
Ligand excluded by PLIPLDA.19: 5 residues within 4Å:- Chain A: V.437, Y.476, P.484, Y.485
- Ligands: LDA.20
Ligand excluded by PLIPLDA.20: 2 residues within 4Å:- Chain A: Y.476
- Ligands: LDA.19
Ligand excluded by PLIPLDA.21: 5 residues within 4Å:- Chain A: V.428, G.443, Y.445, F.468
- Ligands: LDA.10
Ligand excluded by PLIPLDA.22: 4 residues within 4Å:- Chain A: L.165, D.166, Y.171, F.200
Ligand excluded by PLIPLDA.23: 10 residues within 4Å:- Chain A: V.439, W.470, G.472, G.473, V.474, F.486, Y.488, Y.513
- Ligands: LDA.24, LDA.25
Ligand excluded by PLIPLDA.24: 2 residues within 4Å:- Ligands: LDA.23, LDA.25
Ligand excluded by PLIPLDA.25: 5 residues within 4Å:- Chain A: F.486, Y.513
- Ligands: LDA.12, LDA.23, LDA.24
Ligand excluded by PLIPLDA.27: 4 residues within 4Å:- Ligands: FTT.3, FTT.4, FTT.6, LDA.28
Ligand excluded by PLIPLDA.28: 2 residues within 4Å:- Ligands: FTT.3, LDA.27
Ligand excluded by PLIP- 1 x 3PH: 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE(Non-covalent)
- 2 x DPO: DIPHOSPHATE(Non-covalent)(Non-functional Binders)
DPO.29: 6 residues within 4Å:- Chain A: R.363, R.365, K.420, K.422
- Ligands: PA1-GCS-KDO-GMH-GMH-KDO.1, FTT.2
3 PLIP interactions:3 interactions with chain A- Salt bridges: A:R.365, A:K.420, A:K.422
DPO.31: 3 residues within 4Å:- Ligands: PA1-GCS-KDO-GMH-GMH-KDO.1, PA1-GCS-KDO-GMH-GMH-KDO.1, PA1-GCS-KDO-GMH-GMH-KDO.1
No protein-ligand interaction detected (PLIP)- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mathavan, I. et al., Structural Basis for Hijacking Siderophore Receptors by Antimicrobial Lasso Peptides. Nat.Chem.Biol. (2014)
- Release Date
- 2014-04-09
- Peptides
- FERRICHROME-IRON RECEPTOR: A
MICROCIN J25: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x PA1- GCS- KDO- GMH- GMH- KDO: L-glycero-alpha-D-manno-heptopyranose-(1-3)-L-glycero-alpha-D-manno-heptopyranose-(1-5)-[3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid-(2-4)]3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid-(2-6)-2-amino-2-deoxy-beta-D-glucopyranose-(1-6)-2-amino-2-deoxy-alpha-D-glucopyranose
- 4 x FTT: 3-HYDROXY-TETRADECANOIC ACID(Non-covalent)(Non-functional Binders)
- 1 x DAO: LAURIC ACID(Non-covalent)
- 1 x MYR: MYRISTIC ACID(Non-covalent)
- 20 x LDA: LAURYL DIMETHYLAMINE-N-OXIDE(Non-covalent)(Non-functional Binders)
- 1 x 3PH: 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE(Non-covalent)
- 2 x DPO: DIPHOSPHATE(Non-covalent)(Non-functional Binders)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mathavan, I. et al., Structural Basis for Hijacking Siderophore Receptors by Antimicrobial Lasso Peptides. Nat.Chem.Biol. (2014)
- Release Date
- 2014-04-09
- Peptides
- FERRICHROME-IRON RECEPTOR: A
MICROCIN J25: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.